First international Phase III clinical trial of Covid-19 vaccine launched

2020-06-23
|
ChinaMedical

First international Phase III clinical trial of Covid-19 vaccine launched

On June 23, the inactivated vaccine international Clinical (Phase III) by Sinopharm Group's China National Biotec Group (CNBG) was launched in Beijing and Wuhan of China, and Abu Dhabi of UAE, according to media reports.


It is held simultaneously in a video conference. The UAE Minister of Health issued a clinical trial approval document to CNBG.


At the ceremony, China and UAE signed relevant clinical cooperation agreements, marking the launch of the world's first international clinical trial (Phase III) of the inactivated vaccine for Covid-19 virus.



RELATED ARTICLES

Memoray completes tens of millions of yuan in Series B financing
2020-11-18
|
PEVC , Medical care

JD Health and AstraZeneca start strategic cooperation
2020-11-18
|
Medical care , Pharmaceutical

Orthopedic AI company Changmugu closes Series A+ of RMB tens of mlns
2020-09-12
|
PEVC , Medical care

Lu Daopei Medical closes Series B+ exceeding RMB 100 mln
2020-09-11
|
PEVC , Medical care

JD.com reaches strategic cooperation with Tongrentang Health
2020-09-09
|
Medical care , PEVC

Phase III clinical trial of China's covid-19 inactivated vaccine launched in Argentina
2020-08-24
|
Covid-19 , Medical care , Argentina

China started emergency use of Covid-19 vaccine on July 22
2020-08-23
|
Covid-19 , Medical care , Vaccine

First coronavirus vaccine clinical result unveiled: 100% antibody coversion in 28 days
2020-06-16
|
Coronavirus , Medical care
China SDG